ArticlePloS one2025
Isolation, identification, and whole-genome sequencing of Streptomyces rochei FE-3-1 against Pyricularia oryzae.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Streptomyces are significant producers of antimicrobial secondary metabolites. In this study, a Streptomyces rochei FE-3-1was isolated from the rhizosphere of rice plants, and its metabolites exhibited potent antagonistic activity against plant pathogen Pyricularia oryzae. However, the genome sequence of the strain has not been reported to date. Whole genome sequencing and genome mining were conducted to comprehensively characterize the strain's main features. The results showed that the total size of the genome is 8,247,561 bp with 72.51% G + C content. Among a total of 7158 genes, 169 predicted RNA genes were identified including 67 transfer RNA (tRNA) genes, 18 ribosomal RNA (rRNA) genes and 84 small RNA (sRNA) genes, as well as 14 genomic islands were predicted. A total of 31 biosynthetic gene clusters were detected within the genome of Streptomyces rochei FE-3-1, and at least four of these gene clusters are associated with known potent antimicrobials. These findings provide a solid theoretical foundation for utilizing strain FE-3-1 in developing biofertilizers or biopesticides within the field of biotechnology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.